NCT00430092View on ClinicalTrials.gov

Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002b)

PHASE3CompletedINTERVENTIONAL

Enrollment

219

Participants

Timeline

Start Date

Not specified

Conditions

Inflammation

Interventions

DRUG

Difluprednate

DRUG

Difluprednate

DRUG

Placebo

Trial Locations (1)

63090

Comprehensive Eye Care, Washington

All Listed Sponsors

lead

Sirion Therapeutics, Inc.

INDUSTRY